| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 1,000 | ₹1,35,000 |
| HNI / NII | 2 | 2,000 | ₹2,70,000 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII / HNI (Total) | — | 8,70,000 (46.40%) | — | ₹1,174.50 Cr |
| Retail Investors | — | 8,70,000 (46.40%) | — | ₹1,174.50 Cr |
| Total ** | — | 18,75,000 (100.00%) | — | ₹25,312.50 Cr |
| Market Maker * | — | 94,000 (5.01%) | — | ₹12.69 Cr |
| Metric | 30-Sep-22 | 31-Mar-22 | 31-Mar-21 |
|---|---|---|---|
| Revenue | 7985.39 | 10005.25 | 7115.37 |
| PAT | 551.01 | 610.64 | 272.48 |
| EBITDA | — | — | — |
| Net Worth | 1855.77 | 1310.22 | 702.32 |
| Total Assets | 7075.71 | 5899.95 | 3418.27 |
| Reserves | — | — | — |
| Borrowings | 1614.71 | 1385.01 | 579.47 |
Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.